SUNRx offers covered entities an Invoice Analysis and Reconciliation System, which is a real-time toolset that identifies, reports, and recovers contracted, GPO and/or 340B contract pricing discrepancies. Due to the size and complexity of contract portfolios, most subscribers do not have the resources to monitor each line item purchased. SUNRx can do this for you. The SUNRx Inventory Analysis tool is unique in the 340B marketplace, and recovers between 1% and 7% of the total drug spend. Since audits are performed within days of a purchase, subscribers recover the savings faster, at a fraction of the cost of aftermarket auditors. Invoice Analysis is available to any provider type.